1.Damber, JE, Aus, G. Prostate cancer. Lancet. 2008; 371, 1710–1721.
2.Nelen, V. Epidemiology of prostate cancer. Recent Results Cancer Res. 2007; 175, 1–8.
3.Wigle, DT, Turner, MC, Gomes, J, Parent, ME. Role of hormonal and other factors in human prostate cancer. J Toxicol Environ Health B Crit Rev. 2008; 11, 242–259.
4.Ekbom, A. Growing evidence that several human cancers may originate in utero. Semin Cancer Biol. 1998; 8, 237–244.
5.Silva Idos, S, De Stavola, B, McCormack, V. Birth size and breast cancer risk: re-analysis of individual participant data from 32 studies. PLoS Med. 2008; 5, e193.
6.Potischman, N, Troisi, R, Vatten, LJ. The life course approach to cancer epidemiology. In A life course approach to chronic disease epidemiology (eds. Kuh D, Ben-Shlomo Y), 2004; pp. 260–280. New York: Oxford University Press.
7.Henderson, BE, Bernstein, L, Ross, RK, Depue, RH, Judd, HL. The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. Br J Cancer. 1988; 57, 216–218.
8.Ross, RK, Henderson, BE. Do diet and androgens alter prostate cancer risk via a common etiologic pathway? J Natl Cancer Inst. 1994; 86, 252–254.
9.Kaijser, M, Granath, F, Jacobsen, G, Cnattingius, S, Ekbom, A. Maternal pregnancy estriol levels in relation to anamnestic and fetal anthropometric data. Epidemiology. 2000; 11, 315–319.
10.Ekbom, A, Hsieh, CC, Lipworth, L, et al. Perinatal characteristics in relation to incidence of and mortality from prostate cancer. BMJ. 1996; 313, 337–341.
11.Ekbom, A, Wuu, J, Adami, HO, et al. Duration of gestation and prostate cancer risk in offspring. Cancer Epidemiol Biomarkers Prev. 2000; 9, 221–223.
12.Tibblin, G, Eriksson, M, Cnattingius, S, Ekbom, A. High birthweight as a predictor of prostate cancer risk. Epidemiology. 1995; 6, 423–424.
13.Ahlgren, M, Wohlfahrt, J, Olsen, LW, Sörensen, TI, Melbye, M. Birth weight and risk of cancer. Cancer. 2007; 110, 412–419.
14.Cnattingius, S, Lundberg, F, Sandin, S, Gronberg, H, Iliadou, A. Birth characteristics and risk of prostate cancer: the contribution of genetic factors. Cancer Epidemiol Biomarkers Prev. 2009; 18, 2422–2426.
15.Nilsen, TI, Romundstad, PR, Troisi, R, Vatten, LJ. Birth size and subsequent risk for prostate cancer: a prospective population-based study in Norway. Int J Cancer. 2005; 113, 1002–1004.
16.Platz, EA, Giovannucci, E, Rimm, EB, et al. Retrospective analysis of birth weight and prostate cancer in the Health Professionals Follow-up Study. Am J Epidemiol. 1998; 147, 1140–1144.
17.McCormack, VA, dos Santos Silva, I, Koupil, I, Leon, DA, Lithell, HO. Birth characteristics and adult cancer incidence: Swedish cohort of over 11,000 men and women. Int J Cancer. 2005; 115, 611–617.
18.Boland, LL, Mink, PJ, Bushhouse, SA, Folsom, AR. Weight and length at birth and risk of early-onset prostate cancer (United States). Cancer Causes Control. 2003; 14, 335–338.
19.Eriksson, M, Wedel, H, Wallander, MA, et al. The impact of birth weight on prostate cancer incidence and mortality in a population-based study of men born in 1913 and followed up from 50 to 85 years of age. Prostate. 2007; 67, 1247–1254.
20.Oken, E, Gillman, MW. Fetal origins of obesity. Obes Res. 2003; 11, 496–506.
21.Rogers, I. The influence of birthweight and intrauterine environment on adiposity and fat distribution in later life. Int J Obes Relat Metab Disord. 2003; 27, 755–777.
22.MacInnis, RJ, English, DR. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control. 2006; 17, 989–1003.
23.Pischon, T, Boeing, H, Weikert, S, et al. Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2008; 17, 3252–3261.
24.Wallström, P, Bjartell, A, Gullberg, B, Olsson, H, Wirfält, E. A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk. Br J Cancer. 2009; 100, 1799–1805.
25.Riboli, E, Hunt, KJ, Slimani, N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. PHN. 2002; 5, 1113–1124.
26.Berglund, G, Elmståhl, S, Janzon, L, Larsson, SA. The Malmo diet and Cancer study. Design and feasibility. J Intern Med. 1993; 233, 45–51.
27.Manjer, J, Carlsson, S, Elmstahl, S, et al. The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev. 2001; 10, 489–499.
28.Wallström, P, Bjartell, A, Gullberg, B, Olsson, H, Wirfält, E. A prospective study on dietary fat and incidence of prostate cancer (Malmo, Sweden). Cancer Causes Control. 2007; 18, 1107–1121.
29.Statistics Sweden. Occupations in Population and Housing Census 1985, 1985. Statistics Sweden: Stockholm.
30.Lahmann, PH, Gullberg, B, Olsson, H, et al. Birth weight is associated with postmenopausal breast cancer risk in Swedish women. Br J Cancer. 2004; 91, 1666–1668.
31.Janerich, DT, Hayden, CL, Thompson, WD, Selenskas, SL, Mettlin, C. Epidemiologic evidence of perinatal influence in the etiology of adult cancers. J Clin Epidemiol. 1989; 42, 151–157.
32.Zhang, Y, Kreger, BE, Dorgan, JF, et al. Parental age at child's birth and son's risk of prostate cancer. The Framingham Study. Am J Epidemiol. 1999; 150, 1208–1212.
33.Lawlor, DA, Davey Smith, G, Kundu, D, Bruckdorfer, KR, Ebrahim, S. Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? Lancet. 2004; 363, 1724–1727.
34.Trichopoulos, D. Hypothesis: does breast cancer originate in utero? Lancet. 1990; 335, 939–940.
35.Shibata, A, Minn, AY. Perinatal sex hormones and risk of breast and prostate cancers in adulthood. Epidemiol Rev. 2000; 22, 239–248.
36.Johnson, KJ, Springer, NM, Bielinsky, AK, Largaespada, DA, Ross, JA. Developmental origins of cancer. Cancer Res. 2009; 69, 6375–6377.
37.Risnes, KR, Vatten, LJ, Baker, JL, et al. Birthweight and mortality in adulthood: a systematic review and meta-analysis. Int J Epidemiol. 2011; 40, 647–661.